Pirtobrutinib is this non-covalent BTK inhibitor. It’s used for treating mantle cell lymphoma and CLL. The drug goes after the BTK signaling pathway.
It’s super important because it’s key to how these lymphoproliferative diseases survive and progress. You can get it as a tablet in two doses: 50 mg and 100 mg. The usual dose is 200 mg, and you take it every day.
They come in bottles with 60 tablets each. The schedule is tailored to each person, focusing on getting the most out of the drug while trying to keep side effects down.
